Pioglitazone (Old)
70 views
Old Videos
- SSRIs (Old)
- Tricyclic Antidepressants (Old)
- Extrapyramidal Symptoms (Old)
- Ethosuximide (Old)
- Thiazide Diuretics (Old)
- Spironolactone (Old)
- Trazodone (Old)
- Buspirone (Old)
- Loop Diuretics (Old)
- Clonidine (Old)
- Dopamine (Old)
- Beta Blockers (Old)
- Epinephrine (Old)
- Amiodarone (Old)
- Digoxin (Old)
- Non-DHP Calcium Channel Blockers (Old)
- Metformin (Old)
- Statins (Old)
- Insulin Overview (Old)
- Rapid Acting Insulin (Old)
- Short Acting Insulin (Old)
- Canagliflozin (Old)
- Sulfonylureas (Old)
- Pioglitazone (Old)
- DHP Calcium Channel Blockers (Old)
- Hydralazine (Old)
- Nitroglycerin (Old)
- Adenosine (Old)
- Norepinephrine (Old)
Summary
Pioglitazone is an antidiabetic drug that is used to lower blood sugar in patients with type 2 diabetes. Pioglitazone works by lowering insulin resistance, so it actually has a low risk for causing hypoglycemia. Pioglitazone’s main adverse effect is cardiovascular toxicity, meaning there is a chance the pioglitazone causes a myocardial infarction or heart failure.
Key Points
- Pioglitazone
- Mechanism
- Thiazolidinediones
- Decrease insulin resistance and increase blood glucose control
- Carry a low risk for hypoglycemia (similar to metformin)
- Thiazolidinediones
- Clinical Uses
- Hyperglycemia in Type 2 Diabetes Mellitus
- Side Effects and Adverse Reactions
- Cardiovascular Toxicity
- Myocardial Infarction
- Heart Failure
- Can worsen pre-existing heart failure by causing fluid retention
- Bladder Cancer
- Cardiovascular Toxicity
- Mechanism